GE HealthCare stock holds firm as July results top estimates
Published on 08/28/2026 at 13:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
GE HealthCare Technologies Inc. (US36266G1076) stock traded at $72.48 on August 28, 2026, with a market value of $32.74 billion and a one-year range of $58.75 to $89.77. The latest quarterly report, released on July 29, 2026, showed $1.13 in adjusted EPS and $5.29 billion in revenue, both ahead of consensus.
July quarter numbers
The July 29, 2026 quarter mattered because revenue rose 5.8% year over year to $5.29 billion while EPS topped estimates by $0.09. That combination keeps the earnings run rate relevant for investors who are still weighing valuation against execution.
Net margin in the same report was 9.33%, and return on equity reached 20.12%. Those figures give the business a cleaner profit profile than a simple revenue beat would suggest.
What the quote says
The stock opened at $72.48 on August 28, 2026 and sat below the 52-week high of $89.77 but above the low of $58.75. The 200-day moving average was $69.31 and the 50-day moving average was $67.47, which places the shares above both trend markers.
Market cap stood at $32.74 billion, and the price-to-earnings ratio was 16.62. The combination leaves GE HealthCare trading like a profitable large-cap medtech name rather than a fast-growth multiple story.
Imaging still drives
The company's portfolio centers on diagnostic imaging, including MRI, CT, PET and X-ray systems, plus ultrasound, patient monitoring and anesthesia delivery, according to its market profile. That mix matters because the installed base can support recurring service and software revenue alongside equipment sales.
Beckers Hospital Review reported on August 27, 2026 that Intermountain Medical Center became the first hospital in Utah and only the second in the U.S. to use GE HealthCare's SIGNA Sprint Elite MRI system. For investors, that kind of visible placement helps show how flagship imaging products can still win attention in high-end clinical settings.
Trading context
GE HealthCare stock is now priced between the July earnings beat and the wider 2026 trading range. With $1.13 in quarterly EPS, $5.29 billion in revenue and a $32.74 billion market cap all tied to the latest reported period and session, the shares still trade on execution more than hype.
More on GE HealthCare stock
Company: GE HealthCare Technologies Inc.
ISIN: US36266G1076
Ticker: GEHC
Exchange: NASDAQ
Sector / Industry: Healthcare / Medical Devices
Index membership: Nasdaq-100
Market cap: $32.74 billion (as of August 28, 2026)
Price (as of August 28, 2026): $72.48 USD
